Repository series · ncbi-prjeb93812
Whole genome sequencing of Neisseria gonorrhoeae isolates from Vietnam, 2024
The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) was initiated in 2015 in Thailand,1,2 and has now been expanded to include Brazil, Malawi, Cambodia,3,4 Indonesia, The Philippines, South Africa, Thailand,1,2 Uganda, Vietnam,5 and Zimbabwe. Furthermore, Argentina, Côte d'Ivoire, India, and Qatar are in implementation phases. The WHO EGASP uses standardised and quality-assured protocols and in 2023 whole-genome sequencing (WGS), test-of-cure and, extragenital sampling, where feasible, were implemented (https://www.who.int/initiatives/gonococcal-antimicrobial-surveillance-programme). The WHO EGASP-Viet Nam was implemented in the second quarter of 2023 and it is coordinated by the WHO, Geneva, Switzerland; WHO Country Office, Hanoi, Viet Nam; National Hospital of Dermatology and Venereology, Hanoi, Viet Nam; Ho Chi Minh City (HCMC) Hospital of Dermatology and Venereology, HCMC, Viet Nam; Quy Hoa Hospital for Leprosy and Dermatology-Venereology, Quy Hoa, Viet Nam; and the WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections (STIs), Örebro, Sweden. Specimens are collected from males with urethral discharge attending the three participating hospitals in Viet Nam. Specimen collection, transportation, culture, antimicrobial resistance (AMR) testing, and preservation of isolates are performed in strict concordance with the WHO EGASP protocols (https://www.who.int/initiatives/gonococcal-antimicrobial-surveillance-programme).
The accession and its GCC connection are verified. Registration alone does not establish that the broader research programme remains active.
01 / Project overview
What the record establishes.
- Geographic scope
- Qatar connection indexed in BioProject metadata
- Project type
- Repository project
- Research domain
- Pathogen genomics and infectious disease
- Years
- 2025–
- Lifecycle status
- repository_recorded
- Status basis
- Registered in NCBI BioProject on 2025/11/30; operational lifecycle is not asserted.
- Status evidence date
- 2025-11-30
- Scale
- 1 BioProject accession grouped by matching submitter, date, data type and narrative.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Orebro University Hospital
- Partner organizations
- Not stated
- Organism / population
- Not stated
03 / Data and access
What exists and how it can be reached.
Data types
- Other
- Sequencing
- Genome
Data access
Public repository metadata with linked data where supplied by the submitter
Identifiers
- BioProject
PRJEB93812
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Exact country-name match in authoritative NCBI BioProject metadata; repeated submissions are grouped into one Atlas series.
Editorial note
Repository verification confirms the accession and regional connection, not whether the broader research programme remains active.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0